jRCT2031250158进行中（未招募）不适用
Drug-drug interaction study of OP-2024 with Proton pump inhibitor (Rabeprazole Sodium) or Magnesium Oxide in Healthy Male Volunteers
OHARA Pharmaceuitical Co., Ltd0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized Controlled Trial
- 干预模型
- Single Assignment
- 主要目的
- Other
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 18age old over 至 40age old under（—）
- 性别
- Male
入选标准
- •Healthy Japanese male.
- •BMI at time of screening is >= 18.5 to < 25.
- •Written informed consent to participate in this trial can be obtained.
排除标准
- •History of allergies to any component of the investigational product, drug, or food.
- •Subjects with or at risk for angle-closure glaucoma.
- •Subjects with pheochromocytoma or paraganglioma, or other catecholamine-secreting tumors.
- •History of neuroleptic malignant syndrome or nontraumatic rhabdomyolysis.
- •History of diseases affecting the gastrointestinal tract, liver, kidneys, or heart that may influence the absorption, distribution, metabolism, or excretion of drugs.
- •History of major surgery involving the gastrointestinal tract, including gastrectomy, gastrostomy, or bowel resection (excluding appendectomy).
结局指标
主要结局
-
Pharmacokinetics
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
A studyoneJPRN-UMIN000034518ew drug research center, Inc.200
进行中（未招募）
1 期
An Open-label, Multicenter, Phase 1b Study of OV-1001 (Cusatuzumab; Anti-CD70 Monoclonal Antibody) in Combination with Background Therapy for the Treatment of Subjects with Acute Myeloid LeukemiaMedDRA version: 21.0Level: LLTClassification code: 10000886Term: Acute myeloid leukemia Class: 10029104Acute Myeloid LeukemiaCTIS2024-513276-17-00OncoVerity Inc.50
进行中（未招募）
1 期
Phase 1 trial, HMR code: 21-004The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended.Not SpecifiedISRCTN12926361Gedeon Richter Plc104
尚未招募
不适用
The PROGRAM-study: Awake Mapping versus Asleep Mapping versus No Mapping for Glioblastoma Resections: Study Protocol for An International Multicenter Prospective 3-Arm Non-Randomized Clinical TrialGlioblastomaNL-OMON25963one453
已完成
1 期
MK-2420 SAD StudyRheumatoid arthritis2024-511297-73-00Merck Sharp & Dohme LLC96